The Journal of Maternal-Fetal & Neonatal Medicine,
Journal Year:
2022,
Volume and Issue:
35(26), P. 10502 - 10505
Published: Oct. 9, 2022
The
immediate
postpartum
period,
during
delivery
hospitalization,
represents
a
unique
opportunity
to
offer
coronavirus
disease
2019
(COVID-19)
vaccination
those
who
did
not
previously
receive
it.
In
this
study,
we
evaluated
patient
characteristics
associated
with
acceptance
of
in
group.This
retrospective
cohort
study
all
unvaccinated
patients
were
offered
COVID-19
hospitalization
between
May
2021
and
September
at
seven
hospitals
within
large
integrated
health
system
New
York.
During
the
each
hospitalized,
obstetrical
was
vaccine
prior
discharge.
Patients
positive
SARS-CoV-2
PCR
testing
excluded.
Medical
records
reviewed
obtain
sociodemographic
confirm
administration
vaccination.
Multiple
logistic
regression
performed
model
probability
receiving
vaccination.A
total
8,281
included
for
analysis
412
(5%)
received
before
hospital
more
likely
be
older,
have
private
insurance,
decline
answer
questions
about
religious
affiliation,
deliver
final
two
months
period.
Likelihood
affected
by
race-ethnicity,
preferred
language,
marital
status,
parity,
body
mass
index,
or
neighborhood
socioeconomic
conditions.
declined
antibody
compared
(49
vs.
29%;
p
<
.001).Only
5%
It
is
concerning
that
public
insurance
less
This
may
due
variation
counseling
other
unmeasured
factors.
Despite
low
rate
our
population,
should
variety
clinical
settings
maximize
opportunities
administration.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(7), P. 772 - 772
Published: July 14, 2024
Vaccination
among
pregnant
and
breastfeeding
women
is
critical
for
protecting
this
vulnerable
population
their
children.
COVID-19
vaccination
recommended
both
during
pregnancy
breastfeeding;
however,
we
still
do
not
fully
understand
the
determinants
that
influence
hesitancy
towards
vaccination.
This
study
aimed
to
identify
of
vaccine
in
breastfeeding,
puerperium
women.
A
multicenter,
cross-sectional
study,
involving
435
women,
was
conducted.
evaluated
by
administering
Attitudes
(VAX)
Scale
Zung
Anxiety
Self-Assessment
(SAS)
adopted
measure
anxiety
levels.
Overall,
14%
participants
reported
they
did
receive
vaccine,
78.3%
received
first
dose
or
while
breastfeeding.
The
descriptive
statistics
VAX
scale
showed
a
total
mean
score
3.35
(±1.6),
75%
an
index
equal
lower
than
threshold.
Vaccine
increased
as
"adverse
events
after
vaccination"
(
Women s Health Reports,
Journal Year:
2022,
Volume and Issue:
3(1), P. 608 - 616
Published: June 1, 2022
Background:
Pregnant
women
are
at
increased
risk
of
severe
disease
with
coronavirus
2019
(COVID-19).
Despite
strong
recommendations
from
American
College
Obstetricians
and
Gynecologists
Society
for
Maternal
Fetal
Medicine
vaccination,
COVID-19
vaccination
hesitancy
persists.
With
this
study,
we
aim
to
evaluate
opinions
about
the
vaccine
in
a
cohort
high-risk
pregnant
patients.
Materials
Methods:
Institutional
review
board
approval
was
obtained.
Patients
attending
regional
Maternal–Fetal
clinic
central
New
York
were
surveyed
using
standardized
questionnaire.
Demographic,
obstetrical,
medical
information
abstracted
records.
The
vaccinated
unvaccinated
groups
evaluated
chi-square
tests
Bayesian
model.
Results:
Among
157
participants,
38.2%
vaccinated.
There
no
significant
differences
race/ethnicity,
living
situation,
marital
status,
employment
insurance
type,
pregravid
body
mass
index,
history
recreational
drug
use,
number
children,
or
gestational
age
time
survey.
less
formal
education
likely
be
difference
between
influenza
tetanus
diphtheria
pertussis
rates
rates.
Unvaccinated
patients
cite
lack
data
pregnancy
(66%)
as
their
primary
concern.
Most
prefer
learn
vaccines
via
conversation
doctor
(46.7%
59.8%
unvaccinated).
Conclusions:
rate
is
low
our
population.
A
provider-initiated
included
routine
prenatal
care
could
increase
rate.
Journal of Perinatal Medicine,
Journal Year:
2022,
Volume and Issue:
51(1), P. 34 - 38
Published: Sept. 19, 2022
Abstract
COVID-19
is
caused
by
the
2019
novel
coronavirus
(2019-nCoV).
The
first
cases
of
were
identified
in
December
2019,
and
United
States
(US)
case
was
on
January
20th,
2020.
Since
then,
has
spread
throughout
world
declared
a
pandemic
WHO
March
11,
As
July
2022,
about
90
million
persons
have
been
infected
with
US,
there
over
1
deaths
There
224,587
pregnant
patients
COVID-19,
34,527
hospitalized.
Pregnancy
increases
risk
severe
disease
associated
vaccinated
are
significantly
less
likely
to
develop
disease.
Adverse
pregnancy
neonatal
outcomes
more
common
among
women
SARS-CoV-2
during
pregnancy,
especially
those
disease,
vaccination
also
protects
newborn
infant.
intrauterine
transmission
appears
be
rare.
vaccinations
booster
shots
safe.
In
addition,
available
data
suggest
that
antibodies
fetus.
lactating
high
levels
breast
milk.
It
important
future
pandemics
concept
vaccine
recommendations
should
made
early
prevent
maternal,
fetal,
morbidity
mortality.
Physicians
other
healthcare
professionals
strongly
recommend
who
pregnant,
planning
become
breastfeeding.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: Aug. 21, 2024
Introduction
Pregnant
individuals
have
an
increased
risk
of
severe
illness
from
coronavirus
disease
2019
(COVID-19)
infection.
Vaccination
is
effective
strategy
to
prevent
and
complications
for
pregnant
individuals.
are
often
excluded
research
remain
hesitant
receive
vaccination
against
COVID-19.
It
pivotal
study
factors
related
vaccine
uptake
hesitancy
among
We
studied
barriers
facilitators
choice
motivation
regarding
COVID-19
during
pregnancy
aid
future
in
their
decision
vaccinate
various
infectious
agents.
Methods
In
this
qualitative
study,
were
interviewed
between
October
2021
January
2022
using
a
semi-structured
approach.
A
topic
list
was
used
explore
feelings,
perceptions
ideas
pregnancy.
Interviews
transcribed
verbatim
thematic
analyses
performed
MAX
QDA.
Results
After
nine
interviews,
saturation
reached.
Three
main
themes
identified
that
influenced
vaccination:
health
consequences,
ambiguity
information
societal
motivation.
Health
consequences
mainly
concerned
the
effect
offspring,
unknown
long-term
effects
vaccination.
The
advice
Dutch
institute
Public
Environment
changed
not
vaccinating
after
release
developed
vaccine,
routinely
all
data
available
United
States
America
(USA).
This
change
policy
fuelled
doubt
confusion
Arguments
favor
social
perspective
specific
behaviour
rules
restrictions
due
pandemic.
E.g.
without
people
unable
travel
abroad
having
take
test
every
time
entering
public
place.
Conclusion
need
clear,
unambiguous
concerning
short-
long-term,
particularly
decision-making
process
Additionally,
needs
be
addressed.
Besides
aforementioned
themes,
general
counselling
should
focus
on
misperceptions
safety
role
misinformation
which
also
important
non-pregnant
population.
underlines
importance
including
programs
obtain
targeted
needs.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 361 - 361
Published: Feb. 5, 2023
Pregnant
and
breastfeeding
women
comprise
a
high-risk
group
for
the
development
of
severe
COVID-19.
Therefore,
vaccination
is
highly
recommended
perinatal
women;
however,
levels
this
remain
inadequate.
This
study
explores
percentage
COVID-19
among
Saudi
pregnant
lactating
women,
as
well
their
attitudes
toward
it.We
conducted
cross-sectional
questionnaire-based
survey
on
sample
women.
The
included
women.The
vaccine
uptake
was
78.2%.
A
total
45
(21.8%)
out
206
did
not
receive
vaccine.
overall
hesitancy
21.8%.
Breastfeeding
were
2.86
more
likely
to
compared
Being
mother
over
five
children
increased
our
participating
(n
=
20,
90%;
p
<
0.01).
majority
subjects
had
taken
Pfizer
(81.98%,
132/161).
availability
most
common
factor
choosing
particular
Protection
from
infection
(60.2%,
97/161)
reported
main
driver
uptake.
reason
perceived
delaying
being
worried
about
side
effects
(176,
85.44%)
one's
own
body
unborn
child
(130,
63.1%).We
uncovered
high
hesitancy,
primarily
induced
by
concerns
adverse
social
media-related
misinformation.
These
are
due
large-scale
obligatory
program
provided
in
Arabia,
which
well-structured
far
reaching.
Our
results
provide
further
support
so-called
"protection
motivation
theory"
boosting
acceptance.
Counseling
educating
need
hour.
Children,
Journal Year:
2023,
Volume and Issue:
10(4), P. 640 - 640
Published: March 29, 2023
(1)
Background:
Immunization
of
pregnant
women
(PWs)
against
Bordetella
pertussis
infection
is
still
a
challenging
health
matter.
(2)
Methods:
We
gathered
questionnaire
data
from
180
PWs
regarding
their
expectancies
and
current
opinion
on
infectious
disease
prevention.
For
the
group
who
agreed
to
further
investigations,
serum
levels
Ig
G
anti-B.
antibodies
(IgG-PT)
titer
were
measured
analyzed.
(3)
Results:
A
total
completed
98
(54.44%,
study
group)
accepted
perform
laboratory
tests.
During
first
two
pregnancy
trimesters,
found
be
more
willing
(compared
with
control
test
for
identifying
high-risk
situations
that
could
affect
themselves
future
infant
(p
<
0.001).
Most
participating
(91,
91.9%)
had
low
anti-pertussis
(values
40
IU/mL).
Declared
vaccine
coverage
newborn
infants
DTaP-1
Prevenar
13
(at
2
months)
DTaP-2
4
vaccination
reached
100%
in
group,
while
only
30/82
(36.59%)
vaccinated
during
pregnancy,
none
them
providing
infants'
coverage.
(4)
Conclusions:
Enrolled
faced
waning
immunity
B.
infection.
By
raising
maternal
confidence
protective
role
vaccines
diseases,
better
acceptance
can
achieved.